Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Neuroblastoma 2Head and Neck Neoplasms 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Pancreatic Adenocarcinoma 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Meningioma 1Medulloblastoma 1Lung Neoplasms 1Glioma 1Ependymoma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Carcinoma, Ductal, Breast 1

Interventions

Gemcitabine 7130-nm albumin-bound paclitaxel 5Fluorouracil 3Albumin-Bound Paclitaxel 3dehydroftorafur 2Taxes 2Oxaliplatin 2tocilizumab 1selicrelumab 1niraparib 1cobimetinib 1atezolizumab 1Tiragolumab 1Resistance Training 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Pancreatectomy 1PEGPH20 1Nivolumab 1Leucovorin 1Irinotecan 1Ipilimumab 1Interleukin 1 Receptor Antagonist Protein 1Erlotinib Hydrochloride 1Electronic Health Records 1Cisplatin 1Bevacizumab 14-fluorobenzoyl-TN-14003 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pancreatic Adenocarcinoma × Radiotherapy, Image-Guided × Clear all
NCT02427841 2023-09-06

Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

OHSU Knight Cancer Institute

Phase 2 Completed
20 enrolled 17 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡